Synaptic dysfunction in schizophrenia.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1007/978-3-7091-0932-8_22PMID 22351070
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuregulin 1 Promotes Excitatory Synapse Development and Function in GABAergic Interneurons

  2011cited by this paper
• Multiple origins of the cortical gamma rhythm

  2011cited by this paper
• Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance.

  2011cited by this paper
• Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia

  2011cited by this paper
• Alpha7 neuronal nicotinic receptors as targets for novel therapies to treat multiple domains of schizophrenia.

  2011cited by this paper
• Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia.

  2011cited by this paper
• Disrupted Activity in the Hippocampal–Accumbens Circuit of Type III Neuregulin 1 Mutant Mice

  2011cited by this paper
• Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes

  2010cited by this paper
• Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology.

  2010cited by this paper
• Intramembranous Valine Linked to Schizophrenia Is Required for Neuregulin 1 Regulation of the Morphological Development of Cortical Neurons

  2010cited by this paper
• ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation

  2010cited by this paper
• Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling

  2010cited by this paper
• Impaired hippocampal–prefrontal synchrony in a genetic mouse model of schizophrenia

  2010cited by this paper
• NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory.

  2010cited by this paper
• Parvalbumin neurons and gamma rhythms enhance cortical circuit performance

  2009cited by this paper
• Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system

  2009cited by this paper
• Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression.

  2009cited by this paper
• Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia

  2009cited by this paper
• Optical Deconstruction of Parkinsonian Neural Circuitry

  2009cited by this paper
• Selective Expression of ErbB4 in Interneurons, But Not Pyramidal Cells, of the Rodent Hippocampus

  2009cited by this paper
• Presynaptic plasticity: targeted control of inhibitory networks.

  2009cited by this paper
• Differential Regulation of α7 Nicotinic Receptor Gene (CHRNA7) Expression in Schizophrenic Smokers

  2009cited by this paper
• Dysbindin Modulates Prefrontal Cortical Glutamatergic Circuits and Working Memory Function in Mice

  2009cited by this paper
• In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.

  2009cited by this paper
• The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins, and role in neurite outgrowth

  2009cited by this paper
• Expression of ErbB4 in substantia nigra dopamine neurons of monkeys and humans.

  2009cited by this paper
• In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons.

  2009cited by this paper
• The subcellular organization of neocortical excitatory connections

  2009cited by this paper
• Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons

  2009cited by this paper
• Neuregulin Signaling Is Dispensable for NMDA- and GABAA-Receptor Expression in the Cerebellum In Vivo

  2009cited by this paper
• Neuregulin 1 in neural development, synaptic plasticity and schizophrenia

  2008cited by this paper
• A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition

  2008cited by this paper
• Recruitment of PCM1 to the centrosome by the cooperative action of DISC1 and BBS4: a candidate for psychiatric illnesses.

  2008cited by this paper
• Presynaptic Type III Neuregulin1-ErbB signaling targets α7 nicotinic acetylcholine receptors to axons

  2008cited by this paper
• Identification of high risk DISC1 structural variants with a 2% attributable risk for schizophrenia.

  2008cited by this paper
• Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system.

  2008cited by this paper
• Presynaptic Type III Neuregulin 1 Is Required for Sustained Enhancement of Hippocampal Transmission by Nicotine and for Axonal Targeting of α7 Nicotinic Acetylcholine Receptors

  2008cited by this paper
• Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors

  2008cited by this paper
• Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex

  2008cited by this paper
• DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release

  2008cited by this paper
• Neuregulin blocks synaptic strengthening after epileptiform activity in the rat hippocampus.

  2008cited by this paper
• Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients.

  2008cited by this paper
• Neuregulin1 (NRG1) Signaling through Fyn Modulates NMDA Receptor Phosphorylation: Differential Synaptic Function in NRG1+/− Knock-Outs Compared with Wild-Type Mice

  2007cited by this paper
• The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity.

  2007cited by this paper
• Dopamine hypothesis of schizophrenia: Making sense of it all

  2007cited by this paper
• Reversal of Neurological Defects in a Mouse Model of Rett Syndrome

  2007cited by this paper
• Neuregulin-1 enhances depolarization-induced GABA release.

  2007cited by this paper
• Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

  2007cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia.

  2007cited by this paper
• Alpha7 nicotinic acetylcholine receptor mRNA expression and binding in postmortem human brain are associated with genetic variation in neuregulin 1.

  2007cited by this paper
• Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain.

  2007cited by this paper
• Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease.

  2006cited by this paper
• The Relationship Between Prolactin Levels and Glucose Homeostasis in Antipsychotic-treated Schizophrenic Patients

  2006cited by this paper
• Altered neuregulin 1–erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia

  2006cited by this paper
• Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia

  2006cited by this paper
• Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.

  2006cited by this paper
• Altered NMDA receptor expression in schizophrenia

  2006cited by this paper
• Decreased input-specific plasticity of the auditory cortex in mice lacking M1 muscarinic acetylcholine receptors.

  2006cited by this paper
• The involvement of ErbB4 with schizophrenia: Association and expression studies

  2006cited by this paper
• DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex

  2006cited by this paper
• Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia

  2006cited by this paper
• Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls

  2006cited by this paper
• Synaptic plasticity and dysconnection in schizophrenia.

  2006cited by this paper
• DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling

  2005cited by this paper
• Over-Expression of Dopamine D2 Receptor and Inwardly Rectifying Potassium Channel Genes in Drug-Naive Schizophrenic Peripheral Blood Lymphocytes as Potential Diagnostic Markers

  2005cited by this paper
• Regulation of NMDA Receptors by Neuregulin Signaling in Prefrontal Cortex

  2005cited by this paper
• Millisecond-timescale, genetically targeted optical control of neural activity

  2005cited by this paper
• Modulation of Synaptic Plasticity by Physiological Activation of M1 Muscarinic Acetylcholine Receptors in the Mouse Hippocampus

  2005cited by this paper
• A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development

  2005cited by this paper
• Reduced density of cholinergic interneurons in the ventral striatum in schizophrenia: an in situ hybridization study.

  2005cited by this paper
• Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia.

  2005cited by this paper
• The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia.

  2005cited by this paper
• Investigation of M1/M4 Muscarinic Receptors in the Anterior Cingulate Cortex in Schizophrenia, Bipolar Disorder, and Major Depression Disorder

  2004cited by this paper
• Neurotrophic and neuroprotective effects of the neuregulin glial growth factor‐2 on dopaminergic neurons in rat primary midbrain cultures

  2004cited by this paper
• Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.

  2004cited by this paper
• Provocative tests with psychostimulant drugs in schizophrenia

  2004cited by this paper
• C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo

  2004cited by this paper
• M1 Receptor Agonism, a Possible Treatment for Cognitive Deficits in Schizophrenia

  2004cited by this paper
• Interneurons of the neocortical inhibitory system

  2004cited by this paper
• Supranigral injection of neuregulin1-beta induces striatal dopamine overflow.

  2004cited by this paper
• Supranigral injection of neuregulin1-β induces striatal dopamine overflow

  2004cited by this paper
• Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.

  2004cited by this paper
• Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia

  2004cited by this paper
• Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.

  2004cited by this paper
• Dopamine–Glutamate Interactions Controlling Prefrontal Cortical Pyramidal Cell Excitability Involve Multiple Signaling Mechanisms

  2004cited by this paper
• The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame?

  2004cited by this paper
• Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria.

  2004cited by this paper
• The neuregulin receptor, ErbB4, is not required for normal development and adult maintenance of the substantia nigra pars compacta

  2004cited by this paper
• Schizophrenia as a disorder of neuroplasticity.

  2004cited by this paper
• Association of neuregulin 1 with schizophrenia confirmed in a Scottish population.

  2003cited by this paper
• Association study of neuregulin 1 gene with schizophrenia

  2003cited by this paper
• Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia

  2003cited by this paper
• Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families.

  2003cited by this paper
• DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation.

  2003cited by this paper
• Family-based association study of DTNBP1 in 6p22.3 and schizophrenia

  2003cited by this paper
• Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1)

  2003cited by this paper
• Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia

  2003cited by this paper
• Yeast two-hybrid screens implicate DISC1 in brain development and function.

  2003cited by this paper
• Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice

  2003cited by this paper

• Neuronal synaptic architecture revealed by cryo-correlative light and electron microscopy

  2025cites this paper
• Autosomal Recessive Omodysplasia (GPC6-Related) with Treatment-Resistant Schizophrenia

  2025cites this paper
• miRNA-Based Diagnosis of Schizophrenia Using Machine Learning

  2025cites this paper
• Decoding the Nectin Interactome: Implications for Brain Development, Plasticity, and Neurological Disorders.

  2025cites this paper
• Comparative estimation of the effects of antihypertensive medications on schizophrenia occurrence: a multinational observational cohort study

  2024cites this paper
• The Cellular Dysfunction of the Brain–Blood Barrier from Endothelial Cells to Astrocytes: The Pathway towards Neurotransmitter Impairment in Schizophrenia

  2024cites this paper
• What Remains to Be Discovered in Schizophrenia Therapeutics: Contributions by Advancing the Molecular Mechanisms of Drugs for Psychosis and Schizophrenia

  2024cites this paper
• Human umbilical cord blood mesenchymal stem cells mediate microglia activation and improve anxiety-like behavior in MIA-induced offspring of schizophrenic rats.

  2024cites this paper
• A consistent map in the medial entorhinal cortex supports spatial memory

  2024cites this paper
• The cortical hypogyrification pattern in antipsychotic-naive first-episode schizophrenia.

  2023cites this paper
• A consistent map in the medial entorhinal cortex supports spatial memory

  2023cites this paper
• Novel Compounds in the Treatment of Schizophrenia—A Selective Review

  2023cites this paper
• Synaptic dysfunction in schizophrenia

  2023cites this paper
• Deep learning-based synapse counting and synaptic ultrastructure analysis of electron microscopy images.

  2022cites this paper
• Significance of Brain Glucose Hypometabolism, Altered Insulin Signal Transduction, and Insulin Resistance in Several Neurological Diseases

  2022cites this paper
• The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders

  2022cites this paper
• Schizophrenia, Bipolar and Major Depressive Disorders: Overview of Clinical Features, Neurotransmitter Alterations, Pharmacological Interventions, and Impact of Oxidative Stress in the Disease Process.

  2022cites this paper
• Axonal transport deficits in neuropsychiatric disorders.

  2022cites this paper
• Differences of resting fMRI and cognitive function between drug-naïve bipolar disorder and schizophrenia

  2022cites this paper
• The role of integrin beta in schizophrenia: a preliminary exploration

  2022cites this paper
• Synaptic signaling networks encode experience by assuming stimulus-specific and brain-region-specific states

  2021cites this paper
• Altered Circadian Rhythms in a Mouse Model of Neurodevelopmental Disorders Based on Prenatal Maternal Immune Activation.

  2021influential citation
• Synaptic protein interaction networks encode experience by assuming stimulus-specific and brain-region-specific states

  2021cites this paper
• Spinophilin expression in postmortem prefrontal cortex of schizophrenic subjects: Effects of antipsychotic treatment.

  2020cites this paper
• Role of Ash1l in Tourette syndrome and other neurodevelopmental disorders

  2020influential citation
• Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?

  2020cites this paper
• 22q11.2 deletion syndrome and schizophrenia.

  2020cites this paper
• Synaptic Communication Engineering for Future Cognitive Brain–Machine Interfaces

  2019cites this paper
• Optimization and pharmacological characterization of receptor‐mediated Gi/o activation in postmortem human prefrontal cortex

  2019cites this paper
• Aspects of excitatory/inhibitory synapses in multiple brain regions are correlated with levels of brain-derived neurotrophic factor/neurotrophin-3.

  2019cites this paper
• Distinct Time-Course of Alterations of Groups I and II Metabotropic Glutamate Receptor and GABAergic Receptor Expression Along the Dorsoventral Hippocampal Axis in an Animal Model of Psychosis

  2019cites this paper
• Genetic contribution of catechol‐O‐methyltransferase in dorsolateral prefrontal cortex functional changes in the first episode schizophrenia

  2019cites this paper
• Synaptic functions and their disruption in schizophrenia: From clinical evidence to synaptic optogenetics in an animal model

  2019cites this paper
• Ephrin-B3 controls excitatory synapse density through cell-cell competition for EphBs

  2019cites this paper
• Dysregulated Glial Differentiation in Schizophrenia May Be Relieved by Suppression of SMAD4- and REST-Dependent Signaling.

  2019cites this paper
• Postsynaptic SNARE Proteins: Role in Synaptic Transmission and Plasticity.

  2019cites this paper
• Time-Dependent Alterations in the Expression of NMDA Receptor Subunits along the Dorsoventral Hippocampal Axis in an Animal Model of Nascent Psychosis.

  2018cites this paper
• Comprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes

  2018cites this paper
• Integrin activity in neuronal connectivity

  2018cites this paper
• PlexinA2 Forward Signaling through Rap1 GTPases Regulates Dentate Gyrus Development and Schizophrenia-like Behaviors

  2018cites this paper
• A screen for genes that regulate synaptic growth reveals mechanisms that stabilize synaptic strength

  2018cites this paper
• Comprehensive pathway analyses of schizophrenia risk loci point to dysfunctional postsynaptic signaling.

  2018cites this paper
• Convergence of Aberrant Electrophysiological Correlates of Salience, Affective Processing and Stress Reactivity in Patients with Schizophrenia

  2017cites this paper
• Accumulation of minor alleles and risk prediction in schizophrenia

  2017cites this paper
• Altered expression of a unique set of genes reveals complex etiology of Schizophrenia

  2017cites this paper
• Integrated genomics and protein interaction analyses implicate postsynaptic signaling in schizophrenia

  2017cites this paper
• A high-throughput model for investigating neuronal function and synaptic transmission in cultured neuronal networks

  2017cites this paper
• Immediate-Early Genes Modulation by Antipsychotics: Translational Implications for a Putative Gateway to Drug-Induced Long-Term Brain Changes

  2017cites this paper
• Changes in Neuronal Oscillations Accompany the Loss of Hippocampal LTP that Occurs in an Animal Model of Psychosis

  2017cites this paper
• A Non-Canonical Role for Choline Acetyltransferase in Chromatin Organization and the Response to Beta-Amyloid

  2016cites this paper
• Collagen-derived matricryptins promote inhibitory nerve terminal formation in the developing neocortex

  2016influential citation
• Collagen-derived matricryptins promote inhibitory nerve terminal formation in the developing neocortex

  2016cites this paper
• Association of schizophrenia with variants of genes that encode transcription factors

  2015cites this paper
• Reduced SNAP-25 increases PSD-95 mobility and impairs spine morphogenesis

  2015cites this paper
• Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients.

  2015cites this paper
• Increased Blood-Reelin-Levels in First Episode Schizophrenia

  2015cites this paper
• The role of the misfolded prion protein in neurodegeneration

  2015cites this paper
• MicroRNA-137 regulates a glucocorticoid receptor-dependent signalling network: implications for the etiology of schizophrenia.

  2014cites this paper
• Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes.

  2014cites this paper
• Searching for molecular mechanisms of psychiatric diseases: examples from autism to rapid cycling

  2014cites this paper
• Inflammation and the two-hit hypothesis of schizophrenia.

  2014cites this paper
• Prefrontal inefficiency is associated with polygenic risk for schizophrenia.

  2014cites this paper
• Neuronale Korrelate der Überzeugungsattribution bei schizophrenen Patienten

  2014cites this paper
• Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5‐HT)2A and DA D2 antagonism and 5‐HT1A partial agonism

  2014cites this paper
• Mitochondria in glutamatergic nerve terminals are selectively affected by exposure to Aβ1-42 modeling early Alzheimer's disease

  2014cites this paper
• The adenosine neuromodulation system in schizophrenia.

  2014cites this paper
• Complexin2 modulates working memory-related neural activity in patients with schizophrenia

  2014cites this paper
• A novel analog of olanzapine linked to sarcosinyl moiety (PGW5) demonstrates high efficacy and good safety profile in mouse models of schizophrenia.

  2014cites this paper
• The amphetamine sensitization model of schizophrenia symptoms and its effect on schedule-induced polydipsia in the rat

  2014cites this paper
• Nerve growth factor and its receptor in schizophrenia

  2014cites this paper
• Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders

  2013cites this paper
• Fitness, health and exercise training therapy in patients with schizophrenia

  2013cites this paper
• Boar Spermatozoa Within the Oviductal Environment (II): Sperm Capacitation

  2013cites this paper
• Mechanisms underlying synaptic vulnerability and degeneration in neurodegenerative disease

  2013cites this paper
• Characterization of the anxiolytic and sedative profile of JM-20: a novel benzodiazepine–dihydropyridine hybrid molecule

  2013cites this paper
• Neuropsychopharmacology of auditory hallucinations: insights from pharmacological functional MRI and perspectives for future research

  2013cites this paper
• Dysfunction of the Ubiquitin Proteasome and Ubiquitin-Like Systems in Schizophrenia

  2013cites this paper
• Association of the brain-derived neurotrophic factor gene G196A rs6265 polymorphisms and the cognitive function and clinical symptoms of schizophrenia.

  2013cites this paper
• Oligodendroglial Alterations and the Role of Microglia in White Matter Injury: Relevance to Schizophrenia

  2013cites this paper
• Understanding the Neurobiological Basis of Drug Abuse: Comorbidity in Schizophrenia

  2013cites this paper
• eview nflammation and the two-hit hypothesis of schizophrenia

  2013cites this paper
• GABAB receptor trafficking and interacting proteins: targets for the development of highly specific therapeutic strategies to treat neurological disorders?

  2013cites this paper
• Synapto-Protective Drugs Evaluation in Reconstructed Neuronal Network

  2013cites this paper
• BDNF and Schizophrenia: From Neurodevelopment to Neuronal Plasticity, Learning, and Memory

  2013cites this paper
• Regulation of Spine Formation by ErbB4 in PV-Positive Interneurons

  2013cites this paper
• RODENT MODELS OF SCHIZOPHRENIA-LIKE SYMPTOMS INCREASE POLYDIPSIA

  2012cites this paper
• Early Life Seizures and Their Long-term Impacts on Cognition: The Role of Synaptic Plasticity Dysfunctions as an Underlying Mechanism

  2012cites this paper
• Treatment effects in schizophrenia : evidence from neuroimaging

  2012cites this paper